170 related articles for article (PubMed ID: 8245810)
1. Follow-up of abnormal Papanicolaou smears among women of different races.
Carey P; Gjerdingen DK
J Fam Pract; 1993 Dec; 37(6):583-7. PubMed ID: 8245810
[TBL] [Abstract][Full Text] [Related]
2. Race-specific results of Papanicolaou testing and the rate of cervical neoplasia in the National Breast and Cervical Cancer Early Detection Program, 1991-1998 (United States).
Benard VB; Lee NC; Piper M; Richardson L
Cancer Causes Control; 2001 Jan; 12(1):61-8. PubMed ID: 11227926
[TBL] [Abstract][Full Text] [Related]
3. High-grade cervical abnormalities and cervical cancer in women following a negative Pap smear with and without an endocervical component: a cohort study with 10 years of follow-up.
Sultana F; English DR; Simpson JA; Canfell K; Gertig DM; Saville M
Int J Cancer; 2014 Sep; 135(5):1213-9. PubMed ID: 24488882
[TBL] [Abstract][Full Text] [Related]
4. Papanicolaou screening in an urgent care setting.
Dunn TS; Jazbec A; Awad R; Batal H
Am J Obstet Gynecol; 2005 Apr; 192(4):1084-6. PubMed ID: 15846184
[TBL] [Abstract][Full Text] [Related]
5. Management of the mildly abnormal Pap smear: a conservative approach.
Brown MS; Phillips GL
Gynecol Oncol; 1985 Oct; 22(2):149-53. PubMed ID: 2996992
[TBL] [Abstract][Full Text] [Related]
6. Expression of MN/CA9 protein in Papanicolaou smears containing atypical glandular cells of undetermined significance is a diagnostic biomarker of cervical dysplasia and neoplasia.
Liao SY; Stanbridge EJ
Cancer; 2000 Mar; 88(5):1108-21. PubMed ID: 10699902
[TBL] [Abstract][Full Text] [Related]
7. The adequacy of management of women with CIN 2 and CIN 3 Pap smear abnormalities.
Towler BP; Irwig LM; Shelley JM
Med J Aust; 1993 Oct; 159(8):523, 526-8. PubMed ID: 8412951
[TBL] [Abstract][Full Text] [Related]
8. Differences in cervical cancer screening and follow-up for black and white women in the United States.
Ford S; Tarraf W; Williams KP; Roman LA; Leach R
Gynecol Oncol; 2021 Feb; 160(2):369-374. PubMed ID: 33323276
[TBL] [Abstract][Full Text] [Related]
9. Improving adherence to screening follow-up among women with abnormal Pap smears: results from a large clinic-based trial of three intervention strategies.
Marcus AC; Crane LA; Kaplan CP; Reading AE; Savage E; Gunning J; Bernstein G; Berek JS
Med Care; 1992 Mar; 30(3):216-30. PubMed ID: 1538610
[TBL] [Abstract][Full Text] [Related]
10. Determinants of adequate follow-up of an abnormal Papanicolaou result among Jamaican women in Portland, Jamaica.
Jeong SJ; Saroha E; Knight J; Roofe M; Jolly PE
Cancer Epidemiol; 2011 Apr; 35(2):211-6. PubMed ID: 20688592
[TBL] [Abstract][Full Text] [Related]
11. Follow-up of abnormal Papanicolaou smears in a hospital-based adolescent clinic.
Lavin C; Goodman E; Perlman S; Kelly LS; Emans SJ
J Pediatr Adolesc Gynecol; 1997 Aug; 10(3):141-5. PubMed ID: 9288658
[TBL] [Abstract][Full Text] [Related]
12. Do follow-up recommendations for abnormal Papanicolaou smears influence patient adherence?
Melnikow J; Chan BK; Stewart GK
Arch Fam Med; 1999; 8(6):510-4. PubMed ID: 10575390
[TBL] [Abstract][Full Text] [Related]
13. Predictors of Papanicolaou smear return in a hospital-based adolescent and young adult clinic.
Kahn JA; Goodman E; Huang B; Slap GB; Emans SJ
Obstet Gynecol; 2003 Mar; 101(3):490-9. PubMed ID: 12636952
[TBL] [Abstract][Full Text] [Related]
14. Prevalence and Risk Assessment of Cervical Cancer Screening by Papanicolaou Smear and Visual Inspection with Acetic Acid for Pregnant Women at a Thai Provincial Hospital.
Lertcharernrit J; Sananpanichkul P; Suknikhom W; Bhamarapravatana K; Suwannarurk K; Leaungsomnapa Y
Asian Pac J Cancer Prev; 2016; 17(8):4163-7. PubMed ID: 27644678
[TBL] [Abstract][Full Text] [Related]
15. Colposcopy Requirement of Papanicolaou Smear after Atypical Squamous Cells of Undetermined Significance (ASC-US) by Follow-up Protocol in an Urban Gynaecology Clinic, a Retrospective Study in Thailand.
Perksanusak T; Sananpanichkul P; Chirdchim W; Bhamarapravatana K; Suwannarurk K
Asian Pac J Cancer Prev; 2015; 16(12):4977-80. PubMed ID: 26163625
[TBL] [Abstract][Full Text] [Related]
16. Inadequate follow-up for abnormal Pap smears in an urban population.
Peterson NB; Han J; Freund KM
J Natl Med Assoc; 2003 Sep; 95(9):825-32. PubMed ID: 14527050
[TBL] [Abstract][Full Text] [Related]
17. Prevalence of high-risk human papillomavirus in women with abnormal and normal vaginal ThinPrep Papanicolaou cytology.
Bansal M; Zhao C
J Low Genit Tract Dis; 2011 Apr; 15(2):105-9. PubMed ID: 21317806
[TBL] [Abstract][Full Text] [Related]
18. A comparison of the reliability of repeat cervical smears and colposcopy in patients with abnormal cervical cytology.
Mayeaux EJ; Harper MB; Abreo F; Pope JB; Phillips GS
J Fam Pract; 1995 Jan; 40(1):57-62. PubMed ID: 7807039
[TBL] [Abstract][Full Text] [Related]
19. Abnormal Papanicolaou smears and colposcopic follow-up among American Indian and Alaska Native women in the Pacific northwest.
Gilbert TJ; Sugarman JR; Cobb N
J Am Board Fam Pract; 1995; 8(3):183-8. PubMed ID: 7618496
[TBL] [Abstract][Full Text] [Related]
20. Oral contraceptive pills are associated with artifacts in ThinPrep Pap smears that mimic low-grade squamous intraepithelial lesions.
Morrison C; Prokorym P; Piquero C; Wakely PE; Nuovo GJ
Cancer; 2003 Apr; 99(2):75-82. PubMed ID: 12704686
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
